You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫藥股全線下跌 浙江醫用耗材帶量採購方案出爐
格隆匯 05-28 13:04
格隆匯5月28日丨港股市場醫藥股全線下跌,其中,石藥集團大跌12%,康哲藥業、中國生物製藥、石四藥集團均跌超6%,長江生命科技、三生製藥跌超5%,華潤醫藥、麗珠醫藥、復星醫藥等跌超4%。浙江省藥械採購中心25日擬訂了《浙江省公立醫療機構部分醫用耗材帶量採購文件(徵求意見稿)》。公佈了冠脈介入藥物支架、冠脈介入球囊、骨科髖關節醫用耗材的採購方案,採購週期為2年。本次年採購量為浙江省內公立醫療機構2019年全年交易量的80%。對於醫藥股今天的全線下跌,有分析人士稱,浙江方案對中標企業的中標量和價都做了明確規定,這與此前的江蘇、安徽、福建方案僅明確了採購總量的方式不同,可能會帶來企業在降價上新的博弈。另外,醫藥股此前整體上積累了一定的漲幅,短期積聚了一定的獲利盤,資金本身有獲利了結的需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account